268 related articles for article (PubMed ID: 35947146)
1. Efficacy of high-intensity focused ultrasound combined with LNG-IUS for adenomyosis: a systematic review and meta-analysis.
Zhao TT; Pang LL; Yang LL; Li RN; Fan LX; Wen Y
Arch Gynecol Obstet; 2023 Aug; 308(2):351-362. PubMed ID: 35947146
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of High-Intensity Focused Ultrasound Combined With GnRH-a for Adenomyosis: A Systematic Review and Meta-Analysis.
Pang LL; Mei J; Fan LX; Zhao TT; Li RN; Wen Y
Front Public Health; 2021; 9():688264. PubMed ID: 34485218
[No Abstract] [Full Text] [Related]
3. Clinical evaluation of high-intensity focused ultrasound ablation combined with mifepristone and levonorgestrel-releasing intrauterine system to treat symptomatic adenomyosis.
Zhu H; Ma Q; Dong G; Yang L; Li Y; Song S; Mu Y
Int J Hyperthermia; 2023; 40(1):2161641. PubMed ID: 36586419
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the treatment efficacies of HIFU, HIFU combined with GnRH-a, and HIFU combined with GnRH-a and LNG-IUS for adenomyosis: A systematic review and meta-analysis.
Otgontuya A; Jeng CJ; Wu TN; Chuang LT; Shen J
Taiwan J Obstet Gynecol; 2023 Mar; 62(2):226-238. PubMed ID: 36965889
[TBL] [Abstract][Full Text] [Related]
5. High intensity focused ultrasound treatment of adenomyosis: a comparative study.
Guo Q; Xu F; Ding Z; Li P; Wang X; Gao B
Int J Hyperthermia; 2018; 35(1):505-509. PubMed ID: 30306813
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study of high intensity focused ultrasound ablation combined with GnRH-a and LNG-IUS for the treatment of adenomyosis].
Ye MZ; Deng XL; Zhu XG; Xue M
Zhonghua Fu Chan Ke Za Zhi; 2016 Sep; 51(9):643-649. PubMed ID: 27671043
[No Abstract] [Full Text] [Related]
7. Combined therapeutic effects of HIFU, GnRH-a and LNG-IUS for the treatment of severe adenomyosis.
Yang X; Zhang X; Lin B; Feng X; Aili A
Int J Hyperthermia; 2019; 36(1):486-492. PubMed ID: 30994010
[TBL] [Abstract][Full Text] [Related]
8. High-intensity focused ultrasound (HIFU) combined with gonadotropin-releasing hormone analogs (GnRHa) and levonorgestrel-releasing intrauterine system (LNG-IUS) for adenomyosis: a case series with long-term follow up.
Haiyan S; Lin W; Shuhua H; Wang W
Int J Hyperthermia; 2019; 36(1):1179-1185. PubMed ID: 31793356
[No Abstract] [Full Text] [Related]
9. Gonadotrophin-releasing hormone agonist combined with high-intensity focused ultrasound ablation for adenomyosis: a clinical study.
Guo Y; Duan H; Cheng J; Zhang Y
BJOG; 2017 Aug; 124 Suppl 3():7-11. PubMed ID: 28856862
[TBL] [Abstract][Full Text] [Related]
10. The treatment with Levonorgestrel Releasing Intrauterine System (LNG-IUS) in patients affected by menometrorrhagia, dysmenorrhea and adenomimyois: clinical and ultrasonographic reports.
Costanzi F; De Marco MP; Colombrino C; Ciancia M; Torcia F; Ruscito I; Bellati F; Frega A; Cozza G; Caserta D
Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3432-3439. PubMed ID: 34002816
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of HIFU combined with GnRH-a and LNG-IUS for adenomyosis patients who failed to respond to drug therapies: two-year follow-up results.
Peng Y; Dai Y; Yu G; Yang X; Wen C; Jin P
Int J Hyperthermia; 2021; 38(1):1271-1275. PubMed ID: 34423729
[TBL] [Abstract][Full Text] [Related]
12. Treatment of symptomatic adenomyosis with the levonorgestrel-releasing intrauterine system.
Li L; Leng J; Jia S; Lang J
Int J Gynaecol Obstet; 2019 Sep; 146(3):357-363. PubMed ID: 31194884
[TBL] [Abstract][Full Text] [Related]
13. The role of levonorgestrel intra-uterine system in the management of adenomyosis: A systematic review and meta-analysis of prospective studies.
Abbas AM; Samy A; Atwa K; Ghoneim HM; Lotfy M; Saber Mohammed H; Abdellah AM; El Bahie AM; Aboelroose AA; El Gedawy AM; Mostafa M; Elsenity MA; Samy M; Safwat S; Abdelrahman RM; Salah El Din AS; Badran E; Abdelkader AM; Abdallah A
Acta Obstet Gynecol Scand; 2020 May; 99(5):571-581. PubMed ID: 31889294
[TBL] [Abstract][Full Text] [Related]
14. Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial.
Shaaban OM; Ali MK; Sabra AM; Abd El Aal DE
Contraception; 2015 Oct; 92(4):301-7. PubMed ID: 26071673
[TBL] [Abstract][Full Text] [Related]
15. [A prospective cohort study on effects of levonorgestrel-releasing intrauterine system for adenomyosis with severe dysmenorrhea].
Li L; Leng JH; Dai Y; Zhang JJ; Jia SZ; Li XY; Shi JH; Zhang JR; Li T; Xu XX; Liu ZZ; You SS; Chang XY; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):345-51. PubMed ID: 27256441
[TBL] [Abstract][Full Text] [Related]
16. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
Sheng J; Zhang WY; Zhang JP; Lu D
Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671
[TBL] [Abstract][Full Text] [Related]
17. Comparison of efficacy between levonorgestrel intrauterine system and dienogest in adenomyosis: a randomized clinical trial.
Choudhury S; Jena SK; Mitra S; Padhy BM; Mohakud S
Ther Adv Reprod Health; 2024; 18():26334941241227401. PubMed ID: 38283750
[TBL] [Abstract][Full Text] [Related]
18. High-Intensity Focused Ultrasound Combined With Gonadotropin-Releasing Hormone Agonist or Levonorgestrel-Releasing Intrauterine System in Treating Dysmenorrhea of Severe Adenomyosis.
Xu Y; Zhou Z; Wang H; Shao L; Liu G
J Comput Assist Tomogr; 2021 Mar-Apr 01; 45(2):224-231. PubMed ID: 33661158
[TBL] [Abstract][Full Text] [Related]
19. Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system.
Fong YF; Singh K
Contraception; 1999 Sep; 60(3):173-5. PubMed ID: 10640162
[TBL] [Abstract][Full Text] [Related]
20. Comparison of combined transcervical resection of the endometrium and levonorgestrel-containing intrauterine system treatment versus levonorgestrel-containing intrauterine system treatment alone in women with adenomyosis: a prospective clinical trial.
Zheng J; Xia E; Li TC; Sun X
J Reprod Med; 2013; 58(7-8):285-90. PubMed ID: 23947077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
